Health Catalyst Inc (HCAT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Health Catalyst Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 2.10 $ — 39% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 9.5% below the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- -0.05 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.33 | – | 80 | 6.00 | -26.00 | -4 | -8 |
| 2025: Q1 | -0.35 | – | 79 | 6.30 | -29.90 | 0 | 0 |
| 2025: Q2 | -0.59 | – | 81 | 6.30 | -50.80 | -9 | -9 |
| 2025: Q3 | -0.32 | – | 76 | 0.00 | -29.10 | -1 | -5 |
| 2025: Q4 | -1.28 | – | 75 | -6.20 | -121.90 | 10 | 10 |
| 2026: Q1 | -1.53 | – | 71 | -10.90 | -156.90 | 19 | 14 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Health Catalyst, Inc. bietet Datenanalyse-Technologie und -Dienstleistungen für Gesundheitsorganisationen in den USA an.
| Employees | 1,200 |
|---|---|
| Headquarters | South Jordan, UT |
| Website | healthcatalyst.com |
| IPO Date | 25. Jul 2019 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Benjamin Albert | CEO & Director | 1973 |
| Jason Alger | Chief Financial Officer | 1984 |
| Benjamin Landry | General Counsel & Secretary of the Board | 1982 |
| Kyle J. Salyers | Chief Strategy Officer & Senior VP of Corporate Development | – |
| Carrie Kozlowski OT | Chief Marketing Officer | – |
| Jeffrey P. Selander | Senior Vice President of International | – |
| Holly Rimmasch | Senior VP & Chief Clinical Officer | – |
| Linda Llewelyn | Senior Advisor | 1967 |
| Sadiqa Mahmood D.D.S., M.P.H. | GM & Senior VP of Life Sciences Business | – |
| Kristen Berry | Senior Vice President of Public Relations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 16. Jul 2026 | Hoggard Green Jill | Director | Other | 80,691 | 0.00 | – |
| 16. Jul 2026 | Larson-Green Julie | Director | Other | 80,691 | 0.00 | – |
| 16. Jul 2026 | Spencer Justin | Director | Other | 80,691 | 0.00 | – |
| 16. Jul 2026 | Nelson Steven H | Director | Other | 80,691 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.